Found: 7
Select item for more details and to access through your institution.
Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 991, doi. 10.1007/s00280-014-2432-x
- By:
- Publication type:
- Article
Noninfectious Pneumonitis in a Patient With Renal Cell Carcinoma Treated With Everolimus.
- Published in:
- Oncology Nursing Forum, 2011, v. 38, n. 2, p. 125, doi. 10.1188/11.ONF.125-128
- By:
- Publication type:
- Article
Sunitinib in Metastatic Renal Cell Carcinoma: Recommendations for Management of Noncardiovascular Toxicities.
- Published in:
- Oncologist, 2011, v. 16, n. 5, p. 543, doi. 10.1634/theoncologist.2010-0263
- By:
- Publication type:
- Article
Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 5053, doi. 10.2147/OTT.S145295
- By:
- Publication type:
- Article
Optimizing Patient Adherence to Targeted Therapies in Renal Cell Carcinoma.
- Published in:
- Clinical Journal of Oncology Nursing, 2014, v. 18, n. 6, p. 694, doi. 10.1188/14.CJON.694-700
- By:
- Publication type:
- Article
Management of mTOR Inhibitor Side Effects.
- Published in:
- Clinical Journal of Oncology Nursing, 2009, v. 13, p. 19, doi. 10.1188/09.CJON.S2.19-23
- By:
- Publication type:
- Article
Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma.
- Published in:
- Open Access Rheumatology: Research & Reviews, 2017, v. 9, p. 5053, doi. 10.2147/OTT.S145295
- By:
- Publication type:
- Article